MUC1 and non-small cell lung carcinoma: For example, the combination of platinum-based chemotherapy and TG4010, a modified Ankara virus vaccine that expresses MUC-1 and IL-2, was investigated in a phase IIb/III trial involving patients with advanced non-small cell lung cancer (Quoix et al., 2016).